CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC MARROW TRANSPLANTATION

被引：0
作者：
BRENNER, MK
GRIFFITHS, PD
PRENTICE, HG
机构：
[1] ROYAL FREE HOSP,DEPT VIROL,LONDON NW3 2QG,ENGLAND
[2] ROYAL FREE HOSP,BONE MARROW TRANSPLANTAT PROGRAMME,LONDON NW3 2QG,ENGLAND
来源：
LANCET | 1987年 / 2卷 / 8553期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
[21]   DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE IN PNEUMONITIS OCCURRING AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
CORDONNIER, C ;
BERNAUDIN, JF ;
FLEURY, J ;
FEUILHADE, M ;
HAIOUN, C ;
PAYEN, D ;
HUET, Y ;
ATASSI, K ;
VERNANT, JP .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 132 (05) :1118-1123
[22]   DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV) PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
SCHROEDER, M ;
ESSELL, J ;
HARMAN, G ;
HALVORSON, R ;
DOLAN, M ;
CALLANDER, N ;
SNYDER, M ;
WILKS, S ;
ALLERTON, J ;
THOMPSON, J .
BLOOD, 1993, 82 (10) :A425-A425
[23]   PROPHYLAXIS OF CYTOMEGALOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GRIGG, A ;
PHILLIPS, G .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05) :972-972
[24]   PROPHYLAXIS OF CYTOMEGALOVIRUS-INFECTION WITH GANCICLOVIR IN ALLOGENEIC MARROW TRANSPLANTATION [J].
YAU, JC ;
DIMOPOULOS, MA ;
HUAN, SD ;
TARRAND, JJ ;
SPENCER, V ;
SPITZER, G ;
MENEGHETTI, CM ;
WALLERSTEIN, RO ;
ANDERSSON, BS ;
LEMAISTRE, CF .
EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (05) :371-376
[25]   CYTOMEGALOVIRUS INTERSTITIAL PNEUMONITIS FOLLOWING ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION [J].
许晓华 ;
黄连生 ;
张晓红 ;
朱康儿 ;
徐炀 ;
吴东 ;
赵小英 .
ChineseJournalofCancerResearch, 2005, (04) :294-297
[26]   CYTOMEGALOVIRUS ANTIGEN-DETECTION IN PERIPHERAL-BLOOD LEUKOCYTES AFTER ALLOGENEIC MARROW TRANSPLANTATION [J].
BOECKH, M ;
BOWDEN, RA ;
GOODRICH, JM ;
PETTINGER, M ;
MEYERS, JD .
BLOOD, 1992, 80 (05) :1358-1364
[27]   Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation [J].
Szer, J ;
Durrant, S ;
Schwarer, AP ;
Bradstock, KF ;
Gibson, J ;
Arthur, C ;
To, LB ;
Hughes, T ;
Raunow, H .
INTERNAL MEDICINE JOURNAL, 2004, 34 (03) :98-101
[28]   EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
MORI, M ;
GLEAVES, CA ;
DUMOND, C ;
CAYS, M ;
EBELING, DF ;
BUHLES, WC ;
DEARMOND, B ;
MEYERS, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1601-1607
[29]   ABORTIVE HUMAN CYTOMEGALOVIRUS-INFECTION IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
DEGAST, GC ;
BOLAND, GJ ;
VLIEGER, AM ;
DEWEGER, RA ;
VERDONCK, LF ;
ZWAAN, FE ;
JIWA, NM .
BONE MARROW TRANSPLANTATION, 1992, 9 (04) :221-225
[30]   Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor [J].
Takehiko Mori ;
Yoshinobu Aisa ;
Takayuki Shimizu ;
Tomonori Nakazato ;
Rie Yamazaki ;
Yasuo Ikeda ;
Shinichiro Okamoto .
International Journal of Hematology, 2006, 83 :266-270
12345